PLYX Insider Trading Activity and SEC Form 4 Filings
PLYX insider trading summary
Over the past 12 months, insiders at Polaryx Therapeutics, Inc. (PLYX) reported 3 open-market purchases worth $728K by 3 insiders and no sales on SEC Form 4. Net insider buying was $728K.
Latest PLYX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 27, 2026 | Alex Keun Mo Yang | Chief Executive Officer | Buy | $360K (88,453 @ $4.07) |
| May 27, 2026 | Mstone Partners Healthcare Ltd | Director | Buy | $360K (88,453 @ $4.07) |
| Feb 18, 2026 | G. Michael Landis | Chief Financial Officer | Buy | $8K (2,867 @ $2.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.